Shopping Cart
Remove All
Your shopping cart is currently empty
TFSeB is a neuroprotective agent. It reduces STZ-induced MAO-B and AChE activity. TFSeB exerts its neuroprotective effects by increasing the expression of BCL-2, BDNF, and NRF2, while decreasing BAX expression. It also reduces lipid peroxidation (TBARS) and reactive oxygen species (ROS) levels. Additionally, TFSeB alleviates neuroinflammation and is applicable in Alzheimer's disease research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | TFSeB is a neuroprotective agent. It reduces STZ-induced MAO-B and AChE activity. TFSeB exerts its neuroprotective effects by increasing the expression of BCL-2, BDNF, and NRF2, while decreasing BAX expression. It also reduces lipid peroxidation (TBARS) and reactive oxygen species (ROS) levels. Additionally, TFSeB alleviates neuroinflammation and is applicable in Alzheimer's disease research. |
| In vivo | TFSeB (1 mg/kg or 5 mg/kg; i.g.; administered once daily for 20 days) demonstrates neuroprotective effects in male Swiss mice, improving cognitive impairment, reducing oxidative stress and neuroinflammation, and modulating the activity of neurotransmitter-related enzymes. |
| Molecular Weight | 357.23 |
| Formula | C16H13F3OSe |
| Cas No. | 3017240-62-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.